Jump to content
  • Our Mission Pooling competencies – pushing innovations

    BIOPRO Baden-Württemberg GmbH supports the medical technology, biotechnology and pharmaceutical sectors in the healthcare industry in Baden-Württemberg.
    © BIOPRO Baden-Württemberg GmbH

  • Healthcare industry BW Industry report

    We track the economic performance of companies actively engaged in biotechnology, medical technology and pharmaceutical industry. Our publications provide the latest facts und figures for Baden-Württemberg’s healthcare industry.
    © MR.LIGHTMAN / Adobe Stock

  • Season's greetings Happy holidays and a Happy New Year!

    The team of BIOPRO Baden-Württemberg GmbH wishes you and your families happy holidays and a good start into the New Year 2025! After the Christmas break, we will be back for you as usual and look forward to continuing our good and trustful cooperation in the service of the healthcare industry in Baden-Württemberg.

New on ...

... Healthcare industry BW

Natural phenomena are used to find technological solutions in a number of fields. In an interview with BIOPRO, Prof. Dr. Peter M. Kunz discusses groundbreaking innovations emerging from Baden-Württemberg and shares insights on how the principles of bionics can inspire the next generation of innovators.

... Healthcare industry BW

In cases where standard therapies for mental illnesses such as depression prove ineffective, transcranial magnetic stimulation (TMS) offers a promising alternative. This method uses magnetic pulses to stimulate specific regions of the brain. The Tübingen-based company sync2brain has developed a system called ‘bossdevice’ that leverages EEG measurements to tailor this stimulation to each patient's unique brain wave patterns, something that may significantly enhance the therapy's effectiveness.

... Healthcare industry BW

Farewell to animal testing? A closer look at Baden-Württemberg's research landscape reveals how life sciences researchers are pioneering innovative methods to replace animal experiments, minimise the number of animals used and refine the experimental procedures and conditions under which animals are kept. Replace, reduce, refine – these are the guiding principles of the 3Rs principle. The researchers are developing cutting-edge models and establishing a robust 3R network, which not only shapes the future of research but also improves the quality of scientific outcomes. This transformation is funded by the Baden-Württemberg Ministry of Science, Research and the Arts (MWK) with a substantial investment of 6.9 million euros.

... Healthcare industry BW

Certain types of cancer are already being effectively treated using immunotherapies, though success rates can vary significantly between patients. Researchers from the Natural and Medical Sciences Institute (NMI) at the University of Tübingen in Reutlingen, along with colleagues at the University of Tübingen, are working on a diagnostic approach to accompany therapy, which would rapidly assess whether the treatment is effective or requires adjustment. In July 2024, Reutlingen-based immuneAdvice GmbH was spun off from the NMI and is currently putting together an investment consortium to secure follow-up financing.

... Healthcare industry BW

Microscopic examination of tissue samples is essential, particularly in tumour diagnostics. The Tübingen-based company Vicinity Bio leverages cutting-edge imaging technologies combined with machine learning to generate comprehensive datasets of individual cells from tissue sections. This approach not only helps identify more targeted therapies but also enhances our understanding of cellular functions and processes within tissues and tumours.

Website address: https://www.bio-pro.de/en